Phenominer Database Results (179 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
MWF/FubRkb heart weight to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 heart mass not specified 168.0 days 18 2.3 g/kg 0.04 0.17 post excision weight measurement 0.0 65372 117
MWF/FubRkb both kidneys wet weight control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. kidney mass not specified 126.0 days 8 1.67 g 0.13 0.37 post excision weight measurement 0.0 67595 769
MWF/FubRkb count of superficial glomeruli directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. kidney glomerulus quantity not specified 126.0 days 8 2.9 null 0.57 1.6 ex vivo light microscopy 0.0 67601 769
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount female 56.0 days 5.2 mg/d 0.8 enzyme linked immunosorbent assay 0.0 69944 309
MWF/FubRkb timed urine volume control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). urine output not specified 100.0 days 11.3 ml/d 1.1 metabolic cage urine volume measurement method 0.0 108104 3115
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass male 30.0 days 5 98.42 g 0.88 1.96 body weighing method 0.0 109703 3152
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 30.0 days 5 4.9 mg/g 0.13 0.3 post excision weight measurement 0.0 109709 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount male 44.0 days 5 18.4 mg/d 4.65 10.4 enzyme linked immunosorbent assay 0.0 109717 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 31.0 days 5 3.9 x 10E3 um3 0.27 0.6 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109727 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 45.0 days 5 285.9 null 11.99 26.8 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109724 3152
MWF/FubRkb body weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. body mass male 168.0 days 18 363.9 g 11.3 47.94 body weighing method 0.0 108920 3133
MWF/FubRkb single kidney wet weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass female 168.0 days 10 1.2 g 0.03 0.09 post excision weight measurement kidney 0.0 108926 3133
MWF/FubRkb urine total protein excretion rate control condition Schulz A, etal., Physiol Genomics. 2010 Jun. total urine protein amount male 84.0 days 10 47.5 mg/d 6.7 21.19 Bradford protein assay 0.0 108134 3116
MWF/FubRkb urine total protein excretion rate controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 126 days) Schulz A, etal., Physiol Genomics. 2010 Jun. total urine protein amount male 168.0 days 10 308.5 mg/d 24.7 78.11 Bradford protein assay 0.0 108138 3116
MWF/FubRkb tibia length vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. tibia length male 113.0 days 10 4.2 cm 1.0 3.16 post excision length measurement 0.0 109397 3140
MWF/FubRkb kidney glomerular density sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. kidney glomerulus quantity not specified 84.0 days 8 7.3 /mm3 1.6 4.53 ex vivo light microscopy with histochemistry and digital image analysis 0.0 109643 3149
MWF/FubRkb urine albumin excretion rate left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 ml/kg/d) (between 28 and 4 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. urine albumin amount not specified 84.0 days 15 46.6 mg/d 7.7 29.82 enzyme linked immunosorbent assay 0.0 109663 3149
MWF/FubRkb serum creatinine level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood creatinine amount male 168.0 days 10 0.42 mg/dl 0.01 0.04 serum creatinine analysis 0.0 108950 3133
MWF/FubRkb serum creatinine level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood creatinine amount female 168.0 days 10 0.47 mg/dl 0.01 0.04 serum creatinine analysis 0.0 108951 3133
MWF/FubRkb kidney weight controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) Schulz A, etal., Physiol Genomics. 2010 Jun. kidney mass male 84.0 days 1.67 g 0.02 post excision weight measurement kidney 0.0 109046 3116
MWF/FubRkb mesenteric artery wall thickness finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 37.7 um 1.9 6.01 confocal microscopy 0.0 109422 3140
MWF/FubRkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6.0 days 11 0.26 g 0.01 0.03 body weighing method 0.0 109501 3145
MWF/FubRkb body length, crown to rump control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body length not specified -6.0 days 11 13.0 mm 0.3 1.0 body length measuring method 0.0 body length, crown to rump (CMO:0003847) 109509 3145
MWF/FubRkb body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified 100.0 days 334.0 g 6.0 body weighing method 0.0 108083 3115
MWF/FubRkb kidney wet weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2010 Jun. kidney mass male 84.0 days 5.96 mg/g 0.18 post excision weight measurement kidney 0.0 109051 3116
MWF/FubRkb heart weight control condition Schulz A, etal., Physiol Genomics. 2010 Jun. heart mass male 84.0 days 0.75 g 0.02 post excision weight measurement heart 0.0 109057 3116
MWF/FubRkb heart weight to body weight ratio controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) Schulz A, etal., Physiol Genomics. 2010 Jun. heart mass male 84.0 days 2.55 g/kg 0.08 post excision weight measurement heart 0.0 109064 3116
MWF/FubRkb both kidneys wet weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney mass not specified 168.0 days 18 1.99 g 0.08 0.34 post excision weight measurement 0.0 65363 117
MWF/FubRkb body weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. body mass female 168.0 days 18 207.2 g 1.2 5.09 body weighing method 0.0 12760 309
MWF/FubRkb serum total cholesterol level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood cholesterol amount not specified 168.0 days 18 122.01 mg/dl 6.95 29.49 serum total cholesterol measurement test 0.0 serum triglyceride analysis 65391 117
MWF/FubRkb systolic blood pressure control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. arterial blood pressure trait female 168.0 days 18 138.5 mmHg 1.2 5.09 tail cuff plethysmography 0.0 68174 309
MWF/FubRkb serum urea nitrogen level control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. blood urea nitrogen amount female 168.0 days 18 26.11 mg/dl 1.09 4.63 serum urea nitrogen analysis 0.0 68180 309
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount female 168.0 days 24.0 mg/d 5.5 enzyme linked immunosorbent assay 0.0 68185 309
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount female 224.0 days 18.6 mg/d 3.0 enzyme linked immunosorbent assay 0.0 68186 309
MWF/FubRkb norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84.0 days 10 148.4 % 16.0 50.6 wire myography 0.0 norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) 109379 3141
MWF/FubRkb negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84.0 days 10 8.3 null 0.2 0.63 wire myography 0.0 logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) 109384 3141
MWF/FubRkb systolic blood pressure finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. arterial blood pressure trait male 112.0 days 10 133.9 mmHg 9.0 28.46 tail cuff plethysmography 0.0 109410 3140
MWF/FubRkb pulse wave velocity finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. arterial blood pressure trait male 112.0 days 10 5.6 /ms 0.5 1.58 tail cuff plethysmography 0.0 109418 3140
MWF/FubRkb mesenteric artery adventitial thickness finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 7.9 um 0.5 1.58 confocal microscopy 0.0 109426 3140
MWF/FubRkb mesenteric artery media thickness vehicle control condition Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 19.6 um 0.7 2.21 confocal microscopy 0.0 109429 3140
MWF/FubRkb acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasodilation trait male 114.0 days 10 82.3 % 3.0 9.49 wire myography mesenteric artery 0.0 109433 3140
MWF/FubRkb norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasoconstriction trait male 114.0 days 10 77.8 % 10.2 32.26 wire myography 0.0 109441 3140
MWF/FubRkb norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL finerenone (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasoconstriction trait male 114.0 days 10 52.9 % 7.9 24.98 wire myography 0.0 109442 3140
MWF/FubRkb negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasoconstriction trait male 114.0 days 10 6.9 null 0.1 0.32 wire myography 0.0 109445 3140
MWF/FubRkb negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value finerenone (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasoconstriction trait male 114.0 days 10 6.7 null 0.1 0.32 wire myography 0.0 109446 3140
MWF/FubRkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6.0 days 11 0.26 g 0.01 0.03 body weighing method 0.0 109508 3145
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 44.0 days 5 0.96 g 0.06 0.14 post excision weight measurement 0.0 109696 3152
MWF/FubRkb both kidneys wet weight to body weight ratio control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). kidney mass male 100.0 days 10 6.2 g/kg 0.1 0.32 post excision weight measurement 0.0 108102 3115
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass female 44.0 days 5 145.2 g 2.44 5.45 body weighing method 0.0 109706 3152
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass female 58.0 days 5 164.3 g 5.56 12.44 body weighing method 0.0 109708 3152
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 44.0 days 5 4.7 mg/g 0.09 0.2 post excision weight measurement 0.0 109711 3152
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 58.0 days 5 4.4 mg/g 0.13 0.3 post excision weight measurement 0.0 109713 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount female 58.0 days 5 9.5 mg/d 2.95 6.6 enzyme linked immunosorbent assay 0.0 109720 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 31.0 days 5 254.6 null 13.6 30.4 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109721 3152
MWF/FubRkb fetal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified -6.0 days 0.24 g 0.0 body weighing method 0.0 108067 3115
MWF/FubRkb single kidney wet weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass male 168.0 days 10 1.99 g 0.08 0.25 post excision weight measurement kidney 0.0 108927 3133
MWF/FubRkb fetal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified -4.0 days 0.62 g 0.01 body weighing method 0.0 108068 3115
MWF/FubRkb single kidney wet weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass male 168.0 days 10 5.44 g/kg 0.06 0.19 post excision weight measurement kidney 0.0 108932 3133
MWF/FubRkb urine albumin excretion rate sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. urine albumin amount not specified 84.0 days 15 58.1 mg/d 5.8 22.46 enzyme linked immunosorbent assay 0.0 109659 3149
MWF/FubRkb heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 4.5 % 0.3 1.16 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109671 3149
MWF/FubRkb heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 2.3 % 0.2 0.77 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109669 3149
MWF/FubRkb heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 4.3 % 0.7 2.71 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109675 3149
MWF/FubRkb kidney interstitial fibrotic lesion area to total kidney area ratio sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. kidney integrity trait not specified 86.0 days 15 5.0 % 0.4 1.55 ex vivo light microscopy with histochemistry and digital image analysis 0.0 109677 3149
MWF/FubRkb kidney interstitial fibrotic lesion area to total kidney area ratio left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. kidney integrity trait not specified 86.0 days 15 7.8 % 0.6 2.32 ex vivo light microscopy with histochemistry and digital image analysis 0.0 109679 3149
MWF/FubRkb kidney interstitial fibrotic lesion area to total kidney area ratio left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. kidney integrity trait not specified 86.0 days 15 5.4 % 1.1 4.26 ex vivo light microscopy with histochemistry and digital image analysis 0.0 109681 3149
MWF/FubRkb kidney glomerular density control condition Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. kidney glomerulus quantity not specified -2.0 days 15 11.9 /mm3 1.8 6.97 ex vivo light microscopy with digital image analysis 0.0 number of glomeruli per volume of kidney (CMO:0003799) 110785 3187
MWF/FubRkb heart left ventricle weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass male 168.0 days 10 1.86 mg/g 0.02 0.06 post excision weight measurement heart left ventricle 0.0 108944 3133
MWF/FubRkb urine albumin excretion rate control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. urine albumin amount male 56.0 days 18 18.1 mg/d 2.0 8.49 enzyme linked immunosorbent assay 0.0 108965 3133
MWF/FubRkb urine albumin excretion rate control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. urine albumin amount male 84.0 days 10 46.2 mg/d 4.0 12.65 enzyme linked immunosorbent assay 0.0 109286 3141
MWF/FubRkb body weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 body mass not specified 168.0 days 18 363.9 g 11.3 47.94 body weighing method 0.0 65360 117
MWF/FubRkb systolic blood pressure control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 arterial blood pressure trait not specified 173.0 days 18 145.1 mmHg 1.1 4.67 tail cuff piezoplethysmography 0.0 12-18 recordings on 3 consecutive days 11690 117
MWF/FubRkb both kidneys wet weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. kidney mass female 168.0 days 18 1.2 g 0.03 0.13 post excision weight measurement 0.0 12767 309
MWF/FubRkb plasma glucose level control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. blood glucose amount not specified  days 8 157.32 mg/dl 5.6 15.84 plasma glucose analysis 0.0 67603 769
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount male 168.0 days 162.6 mg/d 15.9 enzyme linked immunosorbent assay 0.0 68184 309
MWF/FubRkb creatinine clearance to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. glomerular filtration trait female 168.0 days 18 0.38 ml/min/100g 0.02 0.08 blood creatinine analysis 0.0 68183 309
MWF/FubRkb both kidneys wet weight to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. kidney mass female 168.0 days 18 5.78 g/kg 0.01 0.06 post excision weight measurement 0.0 68171 309
MWF/FubRkb body weight vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. body mass male 112.0 days 10 362.8 g 12.8 40.48 body weighing method 0.0 109389 3140
MWF/FubRkb timed urine volume vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. urine output male 114.0 days 10 10.1 ml/d 0.4 1.26 metabolic cage urine volume measurement method 0.0 109401 3140
MWF/FubRkb mesenteric artery adventitial thickness vehicle control condition Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 8.6 um 0.7 2.21 confocal microscopy 0.0 109425 3140
MWF/FubRkb mesenteric artery media thickness finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 19.3 um 0.9 2.85 confocal microscopy 0.0 109430 3140
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 58.0 days 5 1.06 g 0.04 0.08 post excision weight measurement 0.0 109699 3152
MWF/FubRkb neonatal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified 7.0 days 13.4 g 0.2 body weighing method 0.0 108079 3115
MWF/FubRkb urine albumin excretion rate sham surgical control condition Schulz A, etal., Physiol Genomics. 2010 Jun. urine albumin amount male 84.0 days 10 22.8 mg/d 2.1 6.64 enzyme linked immunosorbent assay 0.0 108123 3116
MWF/FubRkb kidney wet weight to body weight ratio controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) Schulz A, etal., Physiol Genomics. 2010 Jun. kidney mass male 84.0 days 6.18 mg/g 0.1 post excision weight measurement kidney 0.0 109052 3116
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 44.0 days 5 5.0 mg/g 0.13 0.3 post excision weight measurement 0.0 109712 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount male 30.0 days 5 0.14 mg/d 0.05 0.11 enzyme linked immunosorbent assay 0.0 109715 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 59.0 days 5 241.0 null 11.4 25.5 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109725 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 59.0 days 5 248.3 null 19.63 43.9 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109726 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 31.0 days 5 3.5 x 10E3 um3 0.13 0.3 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109728 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 59.0 days 5 6.8 x 10E3 um3 0.31 0.7 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109732 3152
MWF/FubRkb heart weight to body weight ratio control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. heart mass male 84.0 days 10 2.56 g/kg 0.08 0.25 post excision weight measurement 0.0 109280 3141
MWF/FubRkb systolic blood pressure control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). arterial blood pressure trait male 100.0 days 10 159.0 mmHg 6.0 18.97 tail cuff plethysmography 0.0 108098 3115
MWF/FubRkb single kidney wet weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass female 168.0 days 10 5.78 g/kg 0.13 0.41 post excision weight measurement kidney 0.0 108933 3133
MWF/FubRkb heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 3.3 % 0.44 1.7 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109667 3149
MWF/FubRkb heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 1.6 % 0.2 0.77 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109665 3149
MWF/FubRkb heart left ventricle weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass female 168.0 days 10 0.5 g 0.01 0.03 post excision weight measurement heart left ventricle 0.0 108939 3133
MWF/FubRkb creatinine clearance control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. glomerular filtration trait male 168.0 days 10 0.0 ml/min 0.0 0.0 serum creatinine analysis 0.0 108956 3133
MWF/FubRkb creatinine clearance control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. glomerular filtration trait female 168.0 days 10 0.0 ml/min 0.0 0.0 serum creatinine analysis 0.0 108957 3133
MWF/FubRkb kidney glomerulus count control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney glomerulus quantity male 28.0 days 7 N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 27028.0 null 1322.0 3497.68 ex vivo light microscopy with digital image analysis 0.0 108972 3133
MWF/FubRkb body weight control condition Schulz A, etal., Physiol Genomics. 2010 Jun. body mass male 84.0 days 279.3 g 5.5 body weighing method 0.0 109039 3116
MWF/FubRkb both kidneys wet weight to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney mass not specified 168.0 days 18 5.44 g/kg 0.06 0.25 post excision weight measurement 0.0 65366 117
MWF/FubRkb heart wet weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 heart mass not specified 168.0 days 18 0.84 g 0.02 0.08 post excision weight measurement 0.0 65369 117
MWF/FubRkb serum creatinine level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood creatinine amount not specified 168.0 days 18 0.42 mg/dl 0.01 0.05 serum creatinine analysis 0.0 65375 117
MWF/FubRkb serum urea nitrogen level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood urea nitrogen amount not specified 168.0 days 18 26.22 mg/dl 0.73 3.09 serum urea analysis 0.0 serum urea analysis 65382 117
MWF/FubRkb serum triglyceride level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood triglyceride amount not specified 168.0 days 18 95.58 mg/dl 11.5 48.81 serum triglyceride analysis 0.0 serum triglyceride analysis 65386 117
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 224.0 days 10 354.6 mg/d 112.9 357.02 enzyme linked immunosorbent assay 0.0 65419 117
MWF/FubRkb count of superficial glomeruli not directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 168.0 days 18 16.7 null 1.1 4.67 ex vivo light microscopy with digital image analysis 0.0 per section 65458 117
MWF/FubRkb count of superficial glomeruli directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 168.0 days 18 3.8 null 0.8 3.39 ex vivo light microscopy with digital image analysis 0.0 per section 65461 117
MWF/FubRkb body weight control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. body mass not specified 126.0 days 8 333.1 g 6.93 19.6 body weighing method 0.0 67593 769
MWF/FubRkb count of superficial glomeruli not directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. kidney glomerulus quantity not specified 126.0 days 8 19.4 null 1.41 4.0 ex vivo light microscopy 0.0 67599 769
MWF/FubRkb serum creatinine level control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. blood creatinine amount not specified  days 8 0.49 mg/dl 0.0 0.01 serum creatinine analysis 0.0 67605 769
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount female 168.0 days 24.0 mg/d enzyme linked immunosorbent assay 0.0 69947 309
MWF/FubRkb body weight finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. body mass male 112.0 days 10 350.3 g 9.0 28.46 body weighing method 0.0 109390 3140
MWF/FubRkb pulse wave velocity vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. arterial blood pressure trait male 112.0 days 10 5.6 /ms 0.5 1.58 tail cuff plethysmography 0.0 109417 3140
MWF/FubRkb acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. vasodilation trait male 114.0 days 10 89.6 % 1.6 5.06 wire myography mesenteric artery 0.0 109434 3140
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass male 30.0 days 5 0.49 g 0.01 0.03 post excision weight measurement 0.0 109694 3152
MWF/FubRkb heart weight controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) Schulz A, etal., Physiol Genomics. 2010 Jun. heart mass male 84.0 days 0.69 g 0.03 post excision weight measurement heart 0.0 109058 3116
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass female 30.0 days 5 80.61 g 3.72 8.31 body weighing method 0.0 109704 3152
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass male 58.0 days 5 241.28 g 4.47 10.0 body weighing method 0.0 109707 3152
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 30.0 days 5 5.0 mg/g 0.18 0.4 post excision weight measurement 0.0 109710 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount female 44.0 days 5 11.7 mg/d 4.47 10.0 enzyme linked immunosorbent assay 0.0 109718 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount male 58.0 days 5 20.07 mg/d 3.0 6.7 enzyme linked immunosorbent assay 0.0 109719 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 45.0 days 5 279.7 null 19.23 43.0 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109723 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 45.0 days 5 5.9 x 10E3 um3 0.58 1.3 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109730 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 59.0 days 5 7.4 x 10E3 um3 0.49 1.1 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109731 3152
MWF/FubRkb systolic blood pressure control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. arterial blood pressure trait male 84.0 days 10 146.0 mmHg 1.0 3.16 tail cuff plethysmography 0.0 109283 3141
MWF/FubRkb number of glomeruli per kidney to number of ureteric bud tips per kidney ratio control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. kidney glomerulus quantity not specified -6.0 days 11 0.5 null 0.01 0.03 immunofluorescence confocal microscopy 0.0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) 109519 3145
MWF/FubRkb heart left ventricle weight to body weight ratio control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). heart left ventricle mass male 100.0 days 10 1.91 mg/g 0.02 0.06 post excision weight measurement 0.0 108100 3115
MWF/FubRkb creatinine clearance sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. glomerular filtration trait not specified 84.0 days 15 2.36 ml/min 0.14 0.54 urine creatinine analysis 0.0 109646 3149
MWF/FubRkb urine total protein excretion rate sham surgical control condition (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. total urine protein amount not specified 84.0 days 15 79.1 mg/d 9.5 36.79 urine total protein analysis 0.0 109652 3149
MWF/FubRkb urine total protein excretion rate left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. total urine protein amount not specified 84.0 days 15 156.4 mg/d 13.5 52.29 urine total protein analysis 0.0 109655 3149
MWF/FubRkb urine total protein excretion rate left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. total urine protein amount not specified 84.0 days 15 60.4 mg/d 10.1 39.12 urine total protein analysis 0.0 109657 3149
MWF/FubRkb urine albumin excretion rate left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. urine albumin amount not specified 84.0 days 15 124.1 mg/d 10.9 42.22 enzyme linked immunosorbent assay 0.0 109661 3149
MWF/FubRkb kidney glomerular density control condition Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. kidney glomerulus quantity not specified 7.0 days 15 11.3 /mm3 2.6 10.07 ex vivo light microscopy with digital image analysis 0.0 number of glomeruli per volume of kidney (CMO:0003799) 110787 3187
MWF/FubRkb heart left ventricle weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass male 168.0 days 10 0.68 g 0.02 0.06 post excision weight measurement heart left ventricle 0.0 108938 3133
MWF/FubRkb body weight controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) Schulz A, etal., Physiol Genomics. 2010 Jun. body mass male 84.0 days 270.7 g 4.9 body weighing method 0.0 109040 3116
MWF/FubRkb heart wet weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. heart mass female 168.0 days 18 0.62 g 0.01 0.04 post excision weight measurement 0.0 12768 309
MWF/FubRkb heart weight to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. heart mass female 168.0 days 18 2.98 g/kg 0.02 0.08 post excision weight measurement 0.0 12769 309
MWF/FubRkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 56.0 days 18 18.1 mg/d 2.0 8.49 enzyme linked immunosorbent assay 0.0 65273 117
MWF/FubRkb creatinine clearance to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 glomerular filtration trait not specified 168.0 days 18 0.46 ml/min/100g 0.05 0.21 blood creatinine analysis 0.0 65379 117
MWF/FubRkb kidney glomerulus count control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 28.0 days 7 N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 27000.0 null 3500.0 9260.13 ex vivo light microscopy with digital image analysis 0.0 per kidney 65397 117
MWF/FubRkb both kidneys wet weight to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. kidney mass not specified 126.0 days 8 5.01 g/kg 0.36 1.02 post excision weight measurement 0.0 67597 769
MWF/FubRkb serum creatinine level control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. blood creatinine amount female 168.0 days 18 0.47 mg/dl 0.0 0.02 serum creatinine analysis 0.0 68177 309
MWF/FubRkb acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasodilation trait male 84.0 days 10 58.9 % 3.7 11.7 wire myography 0.0 109369 3141
MWF/FubRkb urine albumin excretion rate vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. urine albumin amount male 114.0 days 10 64.4 mg/d 5.6 17.71 enzyme linked immunosorbent assay 0.0 109405 3140
MWF/FubRkb systolic blood pressure vehicle control condition (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. arterial blood pressure trait male 112.0 days 10 151.5 mmHg 9.0 28.46 tail cuff plethysmography 0.0 109409 3140
MWF/FubRkb heart rate vehicle control condition (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. heart pumping trait male 112.0 days 10 352.3 beats/min 7.3 23.08 tail cuff plethysmography heart 0.0 109413 3140
MWF/FubRkb heart rate finerenone (10 mg/kg/d) (for 28 days) Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. heart pumping trait male 112.0 days 10 353.7 beats/min 6.1 19.29 tail cuff plethysmography heart 0.0 109414 3140
MWF/FubRkb mesenteric artery wall thickness vehicle control condition Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. mesenteric artery morphology trait male 114.0 days 10 36.3 um 1.1 3.48 confocal microscopy 0.0 109421 3140
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 30.0 days 5 0.41 g 0.03 0.06 post excision weight measurement 0.0 109695 3152
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 58.0 days 5 0.73 g 0.03 0.07 post excision weight measurement 0.0 109700 3152
MWF/FubRkb kidney weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 44.0 days 5 0.72 g 0.03 0.07 post excision weight measurement 0.0 109697 3152
MWF/FubRkb neonatal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified 1.0 days 6.12 g 0.8 body weighing method 0.0 108077 3115
MWF/FubRkb neonatal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified 12.0 days 21.6 g 0.6 body weighing method 0.0 108081 3115
MWF/FubRkb urine albumin excretion rate control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). urine albumin amount not specified 100.0 days 58.1 mg/d 5.8 enzyme linked immunosorbent assay 0.0 108108 3115
MWF/FubRkb heart weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2010 Jun. heart mass male 84.0 days 2.67 g/kg 0.03 post excision weight measurement heart 0.0 109063 3116
MWF/FubRkb body weight control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. body mass male 44.0 days 5 203.06 g 10.29 23.0 body weighing method 0.0 109705 3152
MWF/FubRkb kidney wet weight to body weight ratio control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. kidney mass female 58.0 days 5 4.4 mg/g 0.09 0.2 post excision weight measurement 0.0 109714 3152
MWF/FubRkb urine albumin excretion rate control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. urine albumin amount female 30.0 days 5 0.11 mg/d 0.02 0.04 enzyme linked immunosorbent assay 0.0 109716 3152
MWF/FubRkb number of podocytes per kidney glomerulus control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait female 31.0 days 5 248.1 null 13.73 30.7 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 109722 3152
MWF/FubRkb glomerular volume per podocyte control condition Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. podocyte morphology trait male 45.0 days 5 6.7 x 10E3 um3 0.54 1.2 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 glomerular volume per podocyte (CMO:0003748) 109729 3152
MWF/FubRkb fetal body weight control condition Rothermund L, etal., J Hypertens. 2006 Sep 24(9). body mass not specified -2.0 days 2.03 g 0.05 body weighing method 0.0 108069 3115
MWF/FubRkb urine albumin excretion rate sham surgical control condition Schulz A, etal., Physiol Genomics. 2010 Jun. urine albumin amount male 168.0 days 10 108.7 mg/d 12.3 38.9 enzyme linked immunosorbent assay 0.0 108124 3116
MWF/FubRkb body weight control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. body mass male 84.0 days 10 302.6 g 4.3 13.6 body weighing method 0.0 109274 3141
MWF/FubRkb kidney wet weight to body weight ratio control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. kidney mass male 84.0 days 10 5.25 mg/g 0.1 0.32 post excision weight measurement 0.0 109277 3141
MWF/FubRkb number of ureteric bud tips per kidney control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. ureteric bud morphology trait not specified -6.0 days 11 77.0 null 3.62 12.0 immunofluorescence confocal microscopy 0.0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) number of ureteric bud tips per kidney (CMO:0003848) 109516 3145
MWF/FubRkb number of glomeruli per kidney control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. kidney glomerulus quantity not specified -6.0 days 11 38.0 null 1.81 6.0 immunofluorescence confocal microscopy 0.0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) 109513 3145
MWF/FubRkb body weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. body mass female 168.0 days 18 207.2 g 1.2 5.09 body weighing method 0.0 108921 3133
MWF/FubRkb urine total protein excretion rate control condition Schulz A, etal., Physiol Genomics. 2010 Jun. total urine protein amount male 168.0 days 10 187.5 mg/d 16.3 51.55 Bradford protein assay 0.0 108135 3116
MWF/FubRkb creatinine clearance left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. glomerular filtration trait not specified 84.0 days 15 0.57 ml/min 0.07 0.27 urine creatinine analysis 0.0 109648 3149
MWF/FubRkb creatinine clearance left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. glomerular filtration trait not specified 84.0 days 15 0.92 ml/min 0.05 0.19 urine creatinine analysis 0.0 109650 3149
MWF/FubRkb heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio left nephrectomy (for 84 days) Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. heart left ventricle integrity trait not specified 86.0 days 15 8.8 % 1.2 4.65 ex vivo light microscopy with histochemistry and digital image analysis heart left ventricle 0.0 109673 3149
MWF/FubRkb heart left ventricle weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass female 168.0 days 10 2.42 mg/g 0.04 0.13 post excision weight measurement heart left ventricle 0.0 108945 3133
MWF/FubRkb serum urea nitrogen level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood urea nitrogen amount male 168.0 days 10 26.22 mg/dl 0.73 2.3 serum urea analysis 0.0 108962 3133
MWF/FubRkb serum urea nitrogen level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood urea nitrogen amount female 168.0 days 10 26.11 mg/dl 1.09 3.45 serum urea analysis 0.0 108963 3133
MWF/FubRkb urine albumin excretion rate control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. urine albumin amount female 56.0 days 18 5.2 mg/d 0.9 3.82 enzyme linked immunosorbent assay 0.0 108969 3133
MWF/FubRkb kidney fibrotic lesion area to total kidney area ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney integrity trait male 168.0 days 10 7.5 % 0.5 1.58 ex vivo light microscopy with digital image analysis kidney 0.0 108984 3133
MWF/FubRkb kidney fibrotic lesion area to total kidney area ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney integrity trait female 168.0 days 10 4.9 % 0.3 0.95 ex vivo light microscopy with digital image analysis kidney 0.0 108985 3133
MWF/FubRkb kidney weight control condition Schulz A, etal., Physiol Genomics. 2010 Jun. kidney mass male 84.0 days 1.67 g 0.05 post excision weight measurement kidney 0.0 109045 3116